Understanding the Invokana Mass Tort
Invokana, a drug used to treat Type 2 diabetes, has been at the center of significant legal scrutiny due to its serious side effects. Initially hailed as a breakthrough in diabetes management, Invokana (Canagliflozin) came under fire when patients began experiencing severe health complications. The U.S. Food and Drug Administration (FDA) issued multiple warnings about the risks associated with the drug, including diabetic ketoacidosis, urinary tract infections, and notably, an increased likelihood of lower limb amputations. This led to the formation of Multidistrict Litigation (MDL) 2750, consolidating over a thousand lawsuits alleging that Janssen Pharmaceuticals and Johnson & Johnson, the manufacturers, failed to adequately warn users of these severe risks. Despite settlements in many of these cases, the litigation continues, reflecting the ongoing concerns over Invokana's safety.
Call Us